Science to Practice: Killing Dormant Cells—Is Targeting Autophagy the Key to Complete Tumor Response in Transarterial Chemoembolization?
- 1 June 2017
- journal article
- editorial
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 283 (3) , 621-623
Abstract
In this issue, Gade et al discovered a unique mechanism of hepatocellular carcinoma cells for surviving the ischemia induced by transarterial embolization/transarterial chemoebolization in a state of cell cycle arrest; this function may serve as a defensive shield against conventional chemotherapeutic agents. SummaryIn this issue of Radiology, Gade et al (1) describe a unique mechanism of hepatocellular carcinoma (HCC) cells for surviving ischemia induced by transarterial embolization (TAE)/transarterial chemoembolization (TACE) in a state of cell cycle arrest—a function that may serve as a defensive shield against conventional chemotherapeutic agents. This finding adds to our knowledge and establishes a previously poorly understood mechanism of chemoresistance in HCC. As the Achilles heel in terms of this process, a concurrent upregulation of autophagic flux as an adaptive response to TAE-like ischemia was found by the authors. This is a targetable mechanism that can potentially be exploited for combined therapeutic approaches of embolotherapy and autophagy inhibition in HCC.Keywords
This publication has 9 references indexed in Scilit:
- Ischemia Induces Quiescence and Autophagy Dependence in Hepatocellular CarcinomaRadiology, 2017
- Egr-1 regulates irradiation-induced autophagy through Atg4B to promote radioresistance in hepatocellular carcinoma cellsOncogenesis, 2017
- The Changes of HIF-1α and VEGF Expression After TACE in Patients With Hepatocellular CarcinomaJournal of Clinical Medicine Research, 2016
- Segmental Transarterial Embolization in a Translational Rat Model of Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2015
- Peptidylarginine deiminase IV promotes the development of chemoresistance through inducing autophagy in hepatocellular carcinomaCell & Bioscience, 2014
- Chloroquine Promotes the Anticancer Effect of TACE in a Rabbit VX2 Liver Tumor ModelInternational Journal of Biological Sciences, 2013
- Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiencyProceedings of the National Academy of Sciences, 2012
- Staying aliveCell Cycle, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011